Skip to main content

Find Clinical Trials

Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Recruiting

Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity Conditioning

NCT03852407

Conditions: Acute Lymphoid Leukemia in Remission, Acute Myeloid Leukemia in Remission, Blood Protein Disorders, +33 more
Locations: ZNA Stuivenberg Antwerp, Belgium

AZ Sint Jan Brugge Bruges, Belgium

IJ Bordet Brussels, Belgium

UZ Brussel Brussels, Belgium

View Trial Details

Recruiting

AZA + Venetoclax as Maintenance Therapy in Younger Adults With AML in First Remission

NCT05404906

Conditions: Acute Myeloid Leukemia (AML) in Remission, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China

The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology Suzhou, Jiangsu, China

View Trial Details

Recruiting

Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid Leukemia

NCT05506332

Conditions: Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse, Hematologic Diseases, +6 more
Locations: University Hospital Antwerp Edegem, Antwerp, Belgium

AZ Delta Roeselare, West Vlaanderen, Belgium

View Trial Details

Recruiting

Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid Leukemia

NCT05445011

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Wuhan Union Hospital Wuhan, Hubei, China

View Trial Details

Recruiting

Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML Profiling

NCT05431257

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: Department of Hematology, Rigshospitalet Copenhagen, Denmark

View Trial Details

Recruiting

A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH

NCT05283993

Conditions: Abnormalities, Multiple, Amyloidosis, Blood Protein Disorders, +44 more
Locations: Peking University First Hospital Beijing, China

View Trial Details

Recruiting

Italian Treatment Free Remission Registry

NCT04769947

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +12 more
Locations: Division of Hematology-AO Mauriziano Hospital, University of Turin Turin, Italy

View Trial Details

Recruiting

CD 70 CAR T for Patients With CD70 Positive Malignant Hematologic Diseases

NCT04662294

Conditions: Acute Myeloid Leukemia, Blood Protein Disorders, Cardiovascular Diseases, +20 more
Locations: The first affiliated hospital of medical college of zhejiang university Hangzhou, Zhejiang, China

View Trial Details

Recruiting

ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.

NCT05038696

Conditions: CAR, CAR T-Cell-Related Encephalopathy Syndrome, Hematologic Diseases, +14 more
Locations: Allen Yeoh Eng Juh Singapore

View Trial Details

Recruiting

Precision Therapy Versus Standard Therapy in AML and MDS in Elderly

NCT05025098

Conditions: AML, Adult, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: Akershus Universitetssykehus Lørenskog, Norway

View Trial Details